Drugs / Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified
Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00220727 | Jul → Oct 2003 | autoimmune thrombocytopenic purpura | Grifols Therapeutics LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00220727 ↗ |
| Route | Intravenous | “Immune Globulin IV [Human]” NCT00220727 ↗ |